Antiproliferative and Cytotoxic Activity of Xanthohumol and Its Non-Estrogenic Derivatives in Colon and Hepatocellular Carcinoma Cell Lines
Autor: | Claudia S. Maier, Adrian F. Gombart, Malcolm B. Lowry, Cristobal L. Miranda, Jan F. Stevens, Isabelle E. Logan |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Cell cycle checkpoint
Colorectal cancer dietary agent phytochemical lcsh:Chemistry chemistry.chemical_compound 0302 clinical medicine Cytotoxic T cell chemoprevention lcsh:QH301-705.5 Spectroscopy 0303 health sciences Propiophenones Communication Cell Cycle Liver Neoplasms apoptosis General Medicine Hep G2 Cells Cell cycle 3. Good health Computer Science Applications colon cancer 030220 oncology & carcinogenesis Xanthohumol Colonic Neoplasms Liver cancer HT29 Cells Carcinoma Hepatocellular Antineoplastic Agents tetrahydroxanthohumol Catalysis Inorganic Chemistry 03 medical and health sciences In vivo medicine Humans flavonoid Physical and Theoretical Chemistry Molecular Biology 030304 developmental biology Cell Proliferation Flavonoids Organic Chemistry medicine.disease HCT116 Cells digestive system diseases xanthohumol polyphenol dihydroxanthohumol chemistry lcsh:Biology (General) lcsh:QD1-999 Apoptosis Cancer research |
Zdroj: | International Journal of Molecular Sciences International Journal of Molecular Sciences, Vol 20, Iss 5, p 1203 (2019) |
ISSN: | 1422-0067 |
Popis: | Xanthohumol (XN), a prenylated flavonoid found in hops, inhibits growth in a variety of cancer cell lines; however, its use raises concerns as gut microbiota and the host’s hepatic cytochrome P450 enzymes metabolize it into the most potent phytoestrogen known, 8-prenylnaringenin (8-PN). The XN derivatives dihydroxanthohumol (DXN) and tetrahydroxanthohumol (TXN) are not metabolized into 8-PN and they show higher tissue concentrations in vivo compared with XN when orally administered to mice at the same dose. Here we show that DXN and TXN possess improved anti-proliferative activity compared with XN in two colon (HCT116, HT29) and two hepatocellular (HepG2, Huh7) carcinoma cell lines, as indicated by their respective IC50 values. Furthermore, XN, DXN, and TXN induce extensive apoptosis in all these carcinoma cell lines. Finally, TXN induces G0/G1 cell cycle arrest in the colon carcinoma cell line HT29. Our findings suggest that DXN and TXN could show promise as therapeutic agents against colorectal and liver cancer in preclinical studies without the drawback of metabolism into a phytoestrogen. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |